Home/Filings/4/0001125345-25-000017
4//SEC Filing

Karrels James 4

Accession 0001125345-25-000017

CIK 0001125345other

Filed

Feb 10, 7:00 PM ET

Accepted

Feb 11, 8:30 PM ET

Size

391.4 KB

Accession

0001125345-25-000017

Insider Transaction Report

Form 4
Period: 2025-02-07
Karrels James
V P, CFO and Secretary
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-08+10,002181,454 total
  • Tax Payment

    Common Stock

    2025-02-08$2.60/sh3,861$10,039177,593 total
  • Award

    Employee Stock Option (right to buy)

    2025-02-07+113,000113,000 total
    Exercise: $2.60Exp: 2035-02-07Common Stock (113,000 underlying)
  • Exercise/Conversion

    Restricted Stock Unit

    2025-02-0810,00219,998 total
    Common Stock (10,002 underlying)
  • Award

    Restricted Stock Unit

    2025-02-07+19,00019,000 total
    Common Stock (19,000 underlying)
Footnotes (4)
  • [F1]On February 8, 2024 the reporting person was granted 30,000 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
  • [F2]Owned jointly with reporting person's wife.
  • [F3]12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.
  • [F4]Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.

Issuer

MACROGENICS INC

CIK 0001125345

Entity typeother

Related Parties

1
  • filerCIK 0001587477

Filing Metadata

Form type
4
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 8:30 PM ET
Size
391.4 KB